21 research outputs found

    Usefulness of qualitative cardiac markers assay in screening and early diagnosis of acute myocardial infarction

    No full text
    ์˜ํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] Acute myocardial infarction is a typical emergent disease in emergency department, but until present, there is a no single tool definitively diagnostic. Point of care tests (POCT) were already introduced in most emergency departments because of it''s use of whole blood, rapid turn around time (TAT) of blood sampling to result, and technical convenience. So, this study was designed to investigate the usefulness of qualitative myoglobin creatine kinase-MB (CK-MB) Troponin I (TnI) assay in screening and early diagnosis of acute myocardial infarction. Material & Method: Cardiac STATusTM (Spectral Diagnostics, Toronto, Canada) as one of qualitative myoglobin CK-MB TnI assay kits was used in this study. In 87 patients, Cardiac STATusTM and central laboratory serum tests for CK-MB and troponin T (TnT) were performed. The sensitivity and the specificity for acute myocardial infarction were evaluated. Based on patient''s record, turn around time (TAT) and kappa statistic for correspondence between the results of Cardiac STATusTM and central laboratory serum tests was evaluated. Result: The sensitivity and specificity of Cardiac STATusTM for acute myocardial infarction was 61.7% and 90%, respectively. There was not different in results between Cardiac STATusTM and serum tests. Kappa statistic of 0.650 showed statistically meaningful correspondence of results between Cardiac STATusTM and serum tests. TAT of Cardiac STATusTM was average 15 minutes, but TAT of serum tests was average 67.3 ยก3/4 20.6 minutes(range: 20๏ฝž126minutes). Conclusion: Cardiac STATusTM was not superior diagnostic tool than central laboratory serum tests in diagnosis of acute myocardial infarction. However, the result of Cardiac STATusTM was meaningful correspondent with that of serum tests and may help medical team to make fast decision and establish early treatment guideline. [์˜๋ฌธ] ๊ธ‰์„ฑ ์‹ฌ๊ทผ๊ฒฝ์ƒ‰์€ ์‘๊ธ‰์‹ค์—์„œ ์ ‘ํ•  ์ˆ˜ ์žˆ๋Š” ๋Œ€ํ‘œ์  ์‘๊ธ‰์งˆํ™˜์ด์ง€๋งŒ ํ˜„์žฌ๊นŒ์ง€ ์กฐ๊ธฐ ์ง„๋‹จ์— ์œ ์šฉํ•œ ๋‹จ์ผ๊ฒ€์‚ฌ๋Š” ์—†๋Š” ์‹ค์ •์ด๋‹ค. ํ˜„์žฅ๊ฒ€์‚ฌ๋Š” ์ „ํ˜ˆ์„ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ๊ฒ€์‚ฌ ๋ฐ ๊ฒฐ๊ณผ์— ์†Œ์š”๋˜๋Š” ์‹œ๊ฐ„์ด ์งง๊ณ , ๊ธฐ์ˆ ์ ์œผ๋กœ ์‰ฝ๋‹ค๋Š” ์žฅ์ ์ด ์žˆ์–ด ์ด๋ฏธ ๋งŽ์€ ์‘๊ธ‰์‹ค์—์„œ ๋„์ž… ๋˜์–ด ์‚ฌ์šฉํ•˜๊ณ  ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ํ˜„์žฅ๊ฒ€์‚ฌ์ธ myoglobin, CK-MB, Troponin I์˜ ์ •์„ฑ๋ถ„์„ ๊ธฐ๊ตฌ๊ฐ€ ๊ธ‰์„ฑ ์‹ฌ๊ทผ๊ฒฝ์ƒ‰์˜ ์„ ๋ณ„ ๋ฐ ์กฐ๊ธฐ์ง„๋‹จ๊ณผ ์กฐ๊ธฐ ์น˜๋ฃŒ์— ๋„์›€์„ ์ฃผ๋Š”์ง€๋ฅผ ์•Œ์•„๋ณด๊ณ ์ž ํ•˜์˜€๋‹ค. ์žฌ๋ฃŒ ๋ฐ ๋ฐฉ๋ฒ•: Myoglobin, CK-MB, Troponin I ์ •์„ฑ๋ถ„์„ ๊ธฐ๊ตฌ๋กœ Cardiac STATusTM (Spectral Diagnostics, Toronto, Canada)๋ฅผ ์‚ฌ์šฉํ•˜์˜€๋‹ค. ์ด 87๋ช…์˜ ํ™˜์ž๋ฅผ ๋Œ€์ƒ์œผ๋กœ Cardiac STATusTM์™€ ํ˜ˆ์ฒญ CK-MB, TnT ๊ฒ€์‚ฌ ๋ฐ ์‹ฌ์ „๋„ ๊ฒ€์‚ฌ๋ฅผ ์‹œํ–‰ํ•˜์˜€๋‹ค. Cardiac STATusTM์˜ ์ง„๋‹จ ์ •ํ™•๋„๋ฅผ ์•Œ์•„๋ณด๊ธฐ ์œ„ํ•ด ๋ฏผ๊ฐ๋„์™€ ํŠน์ด๋„๋ฅผ ์กฐ์‚ฌํ•˜์˜€๊ณ , ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์™€์˜ ๊ฒฐ๊ณผ ์ผ์น˜ ์ •๋„๋Š” ์นดํŒŒ ๊ฐ’(kappa statistic)์„ ์ด์šฉํ•˜์˜€๋‹ค. ํ™˜์ž ๊ธฐ๋ก์ง€๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์— ์†Œ์š”๋˜๋Š” ์‹œ๊ฐ„์„ ์กฐ์‚ฌํ•˜์˜€๋‹ค. ๊ฒฐ๊ณผ: ๊ธ‰์„ฑ ์‹ฌ๊ทผ๊ฒฝ์ƒ‰์— ๋Œ€ํ•œ Cardiac STATusTM๋Š” ๋ฏผ๊ฐ๋„ 61.7%, ํŠน์ด๋„ 90%์˜€์œผ๋ฉฐ, ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์™€ ํฐ ์ฐจ์ด๋ฅผ ๋ณด์ด์ง€ ์•Š์•˜๋‹ค. Cardiac STATusTM์™€ ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์˜ ๊ฒฐ๊ณผ๋Š” ์นดํŒŒ ๊ฐ’ 0.650์œผ๋กœ ์œ ์˜ํ•œ ์ผ์น˜์„ฑ์„ ๋ณด์˜€๋‹ค. ๋˜ํ•œ, Cardiac STATusTM์˜ ๊ฒฐ๊ณผ๋ฅผ ์–ป๊ธฐ๊นŒ์ง€ ํ‰๊ท  15๋ถ„ ์†Œ์š”๋˜๋Š” ๊ฒƒ์— ๋น„ํ•ด ํ˜ˆ์ฒญ ๊ฒ€์‚ฌ๋Š” ํ‰๊ท  67.3 ยฑ 20.6๋ถ„(20๏ฝž126๋ถ„)์ด ์†Œ์š”๋˜์—ˆ๋‹ค. ๊ฒฐ๋ก : Cardiac STATusTM๋Š” ๊ธ‰์„ฑ ์‹ฌ๊ทผ๊ฒฝ์ƒ‰์˜ ์ง„๋‹จ์— ์žˆ์–ด ๋ฏผ๊ฐ๋„์™€ ํŠน์ด๋„๊ฐ€ ๊ธฐ์กด์˜ ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์— ๋น„ํ•ด ์šฐ์›”ํ•˜์ง€๋Š” ์•Š์•˜์œผ๋‚˜, ๊ธฐ์กด์˜ ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์™€ ์œ ์˜ํ•œ ์ผ์น˜์„ฑ์ด ์žˆ๊ณ , ํ˜ˆ์ฒญ๊ฒ€์‚ฌ์— ๋น„ํ•ด ๋น ๋ฅธ ๊ฒฐ๊ณผ ํ™•์ธ์œผ๋กœ ์˜๋ฃŒ์ง„์˜ ๋น ๋ฅธ ์˜์‚ฌ๊ฒฐ์ •๊ณผ ์กฐ๊ธฐ ์น˜๋ฃŒ์ง€์นจ ์„ค์ •์— ๋„์›€์„ ์ค„ ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ํŒ๋‹จ๋œ๋‹ค.ope

    ๊ธฐ์ˆ ์ˆ˜์ค€๊ณผ ๊ณต ์†๋„์— ๋”ฐ๋ฅธ ํƒ๊ตฌ ํฌํ•ธ๋“œ์ŠคํŠธ๋กœํฌ ํƒ€์ด๋ฐ ์ œ์–ด ํŠน์„ฑ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ฒด์œก๊ต์œก๊ณผ,2003.Maste
    corecore